ArticleESMO open2025

A phase I study of AZD8186 in combination with docetaxel in patients with PTEN-mutated or PIK3CB-mutated advanced solid tumors.

A M Schram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.